172 related articles for article (PubMed ID: 3825224)
21. Electrophysiologic effects of intravenous diltiazem in patients with recurrent supraventricular tachycardias.
Roy D; Marchand E; Chabot M; Gagné P; Waters DD; Bourassa MG
Can J Cardiol; 1985; 1(5):302-5. PubMed ID: 3842093
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of postinfarction ventricular tachycardia based on the results of programmed stimulation].
Lukl J; Cernosek B; Heinc P
Vnitr Lek; 1990 Feb; 36(2):121-7. PubMed ID: 2336811
[TBL] [Abstract][Full Text] [Related]
23. Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: evaluation by programmed stimulation and ambulatory electrocardiogram.
Steinbeck G; Bach P; Haberl R
J Am Coll Cardiol; 1986 Oct; 8(4):949-58. PubMed ID: 3760368
[TBL] [Abstract][Full Text] [Related]
24. Dose-related shortening of ventricular tachycardia cycle length after administration of the KATP channel opener bimakalim in a 4-day-old chronic infarct anesthetized pig model.
Aidonidis I; Poyatzi A; Stamatiou G; Lymberi M; Stamatoyannis N; Molyvdas PA
J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):222-30. PubMed ID: 19587223
[TBL] [Abstract][Full Text] [Related]
25. Efficacy, safety, and tolerance of d-sotalol in patients with refractory supraventricular tachyarrhythmias.
Sahar DI; Reiffel JA; Bigger JT; Squatrito A; Kidwell GA
Am Heart J; 1989 Mar; 117(3):562-8. PubMed ID: 2919535
[TBL] [Abstract][Full Text] [Related]
26. Effects of sotalol and d-sotalol on ventricular tachycardia and fibrillation induced by programmed electrical stimulation.
Aliot E; Sadoul N; De Chillou C
Eur Heart J; 1993 Nov; 14 Suppl H():74-7. PubMed ID: 7904940
[TBL] [Abstract][Full Text] [Related]
27. [Results of programmed ventricular stimulation in induced non-sustained polymorphic ventricular tachycardia and maintenance of stimulation].
Brembilla-Perrot B; Takoordyal M; Terrier de la Chaise A; Suty-Selton C; Thiel B; Louis P; Brua JL
Arch Mal Coeur Vaiss; 1991 Jun; 84(6):823-8. PubMed ID: 1898216
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and electrophysiologic effects of oral sotalol in patients with sustained ventricular tachycardia caused by coronary artery disease.
Kus T; Campa MA; Nadeau R; Dubuc M; Kaltenbrunner W; Shenasa M
Am Heart J; 1992 Jan; 123(1):82-9. PubMed ID: 1729853
[TBL] [Abstract][Full Text] [Related]
29. Sotalol.
Hohnloser SH; Woosley RL
N Engl J Med; 1994 Jul; 331(1):31-8. PubMed ID: 8202100
[TBL] [Abstract][Full Text] [Related]
30. A comparison of the long-term effects of sotalol and atenolol on QT interval and arrhythmias after myocardial infarction.
Cobbe SM; Alexopoulos D; Winner SJ; McCaie CP; Cobbe PC; Johnston J
Eur Heart J; 1988 Jan; 9(1):24-31. PubMed ID: 2450026
[TBL] [Abstract][Full Text] [Related]
31. Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias.
Nademanee K; Feld G; Hendrickson J; Singh PN; Singh BN
Circulation; 1985 Sep; 72(3):555-64. PubMed ID: 4017207
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of termination of supraventricular tachycardias by intravenous class III antiarrhythmic agents. A comparison of amiodarone and sotalol.
Waleffe A; Nzayinambaho K; Rodriguez LM; Dehareng A; Kulbertus HE
Eur Heart J; 1989 Dec; 10(12):1084-9. PubMed ID: 2606117
[TBL] [Abstract][Full Text] [Related]
33. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
[TBL] [Abstract][Full Text] [Related]
34. Sotalol in patients with Wolff-Parkinson-White syndrome.
Kunze KP; Schlüter M; Kuck KH
Circulation; 1987 May; 75(5):1050-7. PubMed ID: 3568305
[TBL] [Abstract][Full Text] [Related]
35. Effects of imipramine and amitriptyline on intraventricular conduction, effective refractory period, incidence of ventricular arrhythmias induced by programmed stimulation, and on electrocardiogram after myocardial infarction in dog.
Nishimoto M; Hashimoto H; Ozaki T; Taguchi T; Ohara K; Nakashima M
Arch Int Pharmacodyn Ther; 1994; 328(1):39-53. PubMed ID: 7893190
[TBL] [Abstract][Full Text] [Related]
36. Low-dose oral sotalol for monomorphic ventricular tachycardia: effects during programmed electrical stimulation and follow-up.
Jordaens LJ; Palmer A; Clement DL
Eur Heart J; 1989 Mar; 10(3):218-26. PubMed ID: 2707270
[TBL] [Abstract][Full Text] [Related]
37. Effects of sotalol on ventricular tachycardia and fibrillation produced by programmed electrical stimulation: comparison with other antiarrhythmic agents.
Nademanee K; Singh BN
Am J Cardiol; 1990 Jan; 65(2):53A-57A; discussion 65A-66A. PubMed ID: 2403735
[TBL] [Abstract][Full Text] [Related]
38. Sotalol-induced torsades de pointes in a patient with pre-existent normal response to programmed ventricular stimulation.
Gössinger HD; Siostrzonek P; Schmoliner R; Grimm G; Jäger U; Mösslacher H
Eur Heart J; 1987 Dec; 8(12):1351-3. PubMed ID: 3436333
[No Abstract] [Full Text] [Related]
39. Randomized crossover comparison of the electrophysiologic and antiarrhythmic efficacy of oral cibenzoline and sotalol for sustained ventricular tachycardia.
Hoffmann E; Mattke S; Haberl R; Steinbeck G
J Cardiovasc Pharmacol; 1993 Jan; 21(1):95-100. PubMed ID: 7678686
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of sotalol guided by programmed electrical stimulation for sustained ventricular arrhythmias secondary to coronary artery disease.
Young GD; Kerr CR; Mohama R; Boone J; Yeung-Lai-Wah JA
Am J Cardiol; 1994 Apr; 73(9):677-82. PubMed ID: 8166065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
